- Home
- PB vs TFX Comparison
PB vs TFX Comparison
Compare PB & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PB
- TFX
- Stock Information
- Founded
- PB 1983
- TFX 1943
- Country
- PB United States
- TFX United States
- Employees
- PB N/A
- TFX N/A
- Industry
- PB Major Banks
- TFX Medical/Dental Instruments
- Sector
- PB Finance
- TFX Health Care
- Exchange
- PB Nasdaq
- TFX Nasdaq
- Market Cap
- PB 6.1B
- TFX 6.0B
- IPO Year
- PB 1998
- TFX N/A
- Fundamental
- Price
- PB $65.80
- TFX $129.48
- Analyst Decision
- PB Buy
- TFX Hold
- Analyst Count
- PB 14
- TFX 10
- Target Price
- PB $83.46
- TFX $192.75
- AVG Volume (30 Days)
- PB 686.3K
- TFX 1.6M
- Earning Date
- PB 04-23-2025
- TFX 05-01-2025
- Dividend Yield
- PB 3.53%
- TFX 1.05%
- EPS Growth
- PB 11.89
- TFX N/A
- EPS
- PB 5.05
- TFX 1.48
- Revenue
- PB $1,183,238,000.00
- TFX $3,047,324,000.00
- Revenue This Year
- PB $12.40
- TFX $1.40
- Revenue Next Year
- PB $7.82
- TFX $4.85
- P/E Ratio
- PB $13.04
- TFX $86.90
- Revenue Growth
- PB 8.44
- TFX 2.45
- 52 Week Low
- PB $57.16
- TFX $124.66
- 52 Week High
- PB $86.76
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- PB 39.83
- TFX 38.95
- Support Level
- PB $64.94
- TFX $126.36
- Resistance Level
- PB $67.79
- TFX $132.51
- Average True Range (ATR)
- PB 2.72
- TFX 5.10
- MACD
- PB 0.08
- TFX 0.19
- Stochastic Oscillator
- PB 42.34
- TFX 27.94
About PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.